EC Number | Application | Comment | Organism |
---|---|---|---|
4.3.3.7 | medicine | development of species-specific inhibitors of DHDPS as potential antibacterials | Staphylococcus aureus |
4.3.3.7 | medicine | development of species-specific inhibitors of DHDPS as potential antibacterials | Escherichia coli |
4.3.3.7 | medicine | development of species-specific inhibitors of DHDPS as potential antibacterials | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
4.3.3.7 | (2R,6S)-piperidine-2,6-dicarboxylic acid | 20 mM, 49% inhibition | Escherichia coli | |
4.3.3.7 | (2R,6S)-piperidine-2,6-dicarboxylic acid | 20 mM, 43% inhibition; 20 mM, 77% inhibition | Mycobacterium tuberculosis | |
4.3.3.7 | (2R,6S)-piperidine-2,6-dicarboxylic acid | 20 mM, 51% inhibition | Staphylococcus aureus | |
4.3.3.7 | 4-oxo-1,4-dihydropyridine-2,6-dicarboxylic acid | - |
Escherichia coli | |
4.3.3.7 | 4-oxo-1,4-dihydropyridine-2,6-dicarboxylic acid | 20 mM, 73% inhibition | Mycobacterium tuberculosis | |
4.3.3.7 | 4-oxo-1,4-dihydropyridine-2,6-dicarboxylic acid | 20 mM, 83% inhibition | Staphylococcus aureus | |
4.3.3.7 | cis-(1SS,3R5S)-3,5-thiomorpholinedicarboxylic acid, dimethyl ester, 1-oxide | 20 mM, 8% inhibition | Escherichia coli | |
4.3.3.7 | cis-(1SS,3R5S)-3,5-thiomorpholinedicarboxylic acid, dimethyl ester, 1-oxide | 20 mM, 8% inhibition | Mycobacterium tuberculosis | |
4.3.3.7 | cis-(1SS,3R5S)-3,5-thiomorpholinedicarboxylic acid, dimethyl ester, 1-oxide | 20 mM, 10% inhibition | Staphylococcus aureus | |
4.3.3.7 | dimethyl (2R,6S)-piperidine-2,6-dicarboxylate | 20 mM, 92% inhibition | Escherichia coli | |
4.3.3.7 | dimethyl (2R,6S)-piperidine-2,6-dicarboxylate | 20 mM, 24% inhibition; 20 mM, 99% inhibitione | Mycobacterium tuberculosis | |
4.3.3.7 | dimethyl (2R,6S)-piperidine-2,6-dicarboxylate | 20 mM, 58% inhibition | Staphylococcus aureus | |
4.3.3.7 | dimethyl (3R,5R)-thiomorpholine-3,5-dicarboxylate | 20 mM, 12% inhibition | Escherichia coli | |
4.3.3.7 | dimethyl (3R,5R)-thiomorpholine-3,5-dicarboxylate | 20 mM, 19% inhibition | Mycobacterium tuberculosis | |
4.3.3.7 | dimethyl (3R,5R)-thiomorpholine-3,5-dicarboxylate 1,1-dioxide | 20 mM, 14% inhibition | Escherichia coli | |
4.3.3.7 | dimethyl (3R,5R)-thiomorpholine-3,5-dicarboxylate 1,1-dioxide | 20 mM, 6% inhibition; 20 mM, 7% inhibition | Mycobacterium tuberculosis | |
4.3.3.7 | dimethyl (3R,5R)-thiomorpholine-3,5-dicarboxylate 1-oxide | 20 mM, 7% inhibition | Mycobacterium tuberculosis | |
4.3.3.7 | dimethyl (3R,5R)-thiomorpholine-3,5-dicarboxylate 1-oxide | 20 mM, 7% inhibition | Staphylococcus aureus | |
4.3.3.7 | dimethyl (3R,5S)-thiomorpholine-3,5-dicarboxylate | 20 mM, 35% inhibition | Escherichia coli | |
4.3.3.7 | dimethyl (3R,5S)-thiomorpholine-3,5-dicarboxylate | 20 mM, 23% inhibition | Mycobacterium tuberculosis | |
4.3.3.7 | dimethyl (3R,5S)-thiomorpholine-3,5-dicarboxylate 1,1-dioxide | 20 mM, 19% inhibition; 20 mM, 6% inhibition | Mycobacterium tuberculosis | |
4.3.3.7 | dimethyl 4-oxo-1,4-dihydropyridine-2,6-dicarboxylate | - |
Escherichia coli | |
4.3.3.7 | dimethyl 4-oxo-1,4-dihydropyridine-2,6-dicarboxylate | 20 mM, 84% inhibition | Mycobacterium tuberculosis | |
4.3.3.7 | dimethyl 4-oxo-1,4-dihydropyridine-2,6-dicarboxylate | 20 mM, 88% inhibition | Staphylococcus aureus | |
4.3.3.7 | dimethyl pyridine-2,6-dicarboxylate | 20 mM, 5% inhibition | Escherichia coli | |
4.3.3.7 | dimethyl pyridine-2,6-dicarboxylate | 20 mM, 13% inhibition | Mycobacterium tuberculosis | |
4.3.3.7 | pyridine-2,6-dicarboxylic acid | - |
Escherichia coli | |
4.3.3.7 | pyridine-2,6-dicarboxylic acid | 20 mM, 75% inhibition; 20 mM, 80% inhibition | Mycobacterium tuberculosis | |
4.3.3.7 | pyridine-2,6-dicarboxylic acid | 20 mM, 67% inhibition | Staphylococcus aureus | |
4.3.3.7 | trans-(1SS,3R5S)-3,5-thiomorpholinedicarboxylic acid, dimethyl ester, 1-oxide | 20 mM, 20% inhibition | Escherichia coli | |
4.3.3.7 | trans-(1SS,3R5S)-3,5-thiomorpholinedicarboxylic acid, dimethyl ester, 1-oxide | 20 mM, 14% inhibition; 20 mM, 22% inhibition | Mycobacterium tuberculosis | |
4.3.3.7 | trans-(1SS,3R5S)-3,5-thiomorpholinedicarboxylic acid, dimethyl ester, 1-oxide | 20 mM, 12% inhibition | Staphylococcus aureus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
4.3.3.7 | Escherichia coli | - |
- |
- |
4.3.3.7 | Mycobacterium tuberculosis | - |
- |
- |
4.3.3.7 | Staphylococcus aureus | - |
methicillin-resistant | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
4.3.3.7 | DHDPS | - |
Escherichia coli |
4.3.3.7 | DHDPS | - |
Mycobacterium tuberculosis |